{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:49:58Z","timestamp":1774342198180,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.neulet.2003.11.006","type":"journal-article","created":{"date-parts":[[2003,12,11]],"date-time":"2003-12-11T07:47:40Z","timestamp":1071128860000},"page":"193-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease"],"prefix":"10.1016","volume":"355","author":[{"given":"Jian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo-Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2003.11.006_BIB1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors","volume":"123","author":"Fenelon","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2003.11.006_BIB2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/sj.tpj.6500026","article-title":"The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression","volume":"1","author":"Fuke","year":"2001","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.neulet.2003.11.006_BIB3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson's disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2003.11.006_BIB4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archneur.58.2.209","article-title":"Genetic variation analysis in Parkinson disease patients with and without hallucinations: case-control study","volume":"58","author":"Goetz","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2003.11.006_BIB5","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/2.12.2197-a","article-title":"PCR detection of the TaqI A RFLP at the DRD2 locus","volume":"2","author":"Grandy","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2003.11.006_BIB6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1096-8628(19960216)67:1<63::AID-AJMG11>3.0.CO;2-N","article-title":"Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia","volume":"67","author":"Griffon","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neulet.2003.11.006_BIB7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.mp.4000532","article-title":"Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers","volume":"4","author":"Jonsson","year":"1999","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2003.11.006_BIB8","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.WNL.0000068009.32067.A1","article-title":"L-Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism","volume":"60","author":"Kaiser","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2003.11.006_BIB9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3346\/jkms.2000.15.4.449","article-title":"Association of the dopamine transporter gene with Parkinson's disease in Korean patients","volume":"15","author":"Kim","year":"2000","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.neulet.2003.11.006_BIB10","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/mds.870120523","article-title":"Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease","volume":"12","author":"Le Couteur","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2003.11.006_BIB11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1006\/bbrc.1996.1296","article-title":"Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system","volume":"225","author":"Lundstrom","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2003.11.006_BIB12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00008571-200002000-00006","article-title":"Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease","volume":"10","author":"Makoff","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.neulet.2003.11.006_BIB13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.mp.4000921","article-title":"Polymorphisms in the 3\u2032-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression","volume":"7","author":"Miller","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2003.11.006_BIB14","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/WNL.53.7.1425","article-title":"Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD","volume":"53","author":"Oliveri","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2003.11.006_BIB15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1021648128758","article-title":"Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics","volume":"28","author":"Ritchie","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neulet.2003.11.006_BIB16","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1212\/WNL.56.12.1757","article-title":"Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD","volume":"56","author":"Wang","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2003.11.006_BIB17","first-page":"346","article-title":"Association between genetic polymorphism of dopamine transporter gene and susceptibility to Parkinson's disease","volume":"80","author":"Wang","year":"2000","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.neulet.2003.11.006_BIB18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(01)01971-1","article-title":"Dopamine D5 receptor gene polymorphism and the risk of levodopa-induced motor fluctuations in patients with Parkinson's disease","volume":"308","author":"Wang","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2003.11.006_BIB19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00008571-200306000-00008","article-title":"Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease","volume":"13","author":"Wang","year":"2003","journal-title":"Pharmacogenetics"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394003013168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394003013168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:02:34Z","timestamp":1759608154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394003013168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0304394003013168"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2003.11.006","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2003.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}